Back

ARK Genomic Revolution ETF

Ticker: ARKG ISIN: US00214Q3020
Add to portfolio Portfolio analysis in 2min
ETF Concentrated top holdings
Morningstar
TER
0.75%
Fund size
$1.25B
Holdings
29
Top 10
58.7%
Issuer
ARK ETF Trust
$48.01 -2.91%
Price as of 2026-08-24 · BATS

Performance by timeframe

Rolling returns
1 Month +27.04%
6 Months +62.69%
1 Year +94.14%
5 Years -10.23% p.a.-41.67%
10 Years +10.90% p.a.+181.25%
Since inception +8.35% p.a.+157.95%
Calendar year returns
YTD +65.72%
2025 +23.04%
2024 -28.24%
2023 +16.22%
2022 -53.90%
2021 -33.92%

Key stats

AUM
1.25B
Expense ratio
0.75%
Holdings
29
1Y return
94.14%
Volatility (1Y)
44.52%
52-week range
20.26 - 34.39
Section 1

Fund overview

Fund profile data from fundamentals.

The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies). It is non-diversified.

Category Health
Issuer ARK ETF Trust
Domicile USA
Section 2

Exposure breakdown

Exposure breakdown shows how the fund is allocated across assets, sectors, regions, and size buckets.

Asset allocation

Stock US
88.50%
Stock non-US
11.37%
Cash
0.13%

Sectors

Healthcare
100.00%

Regions

North America
88.61%
Europe Developed
8.95%
United Kingdom
2.44%

Market cap mix

Micro
54.64%
Small
23.72%
Medium
17.05%
Mega
0.95%
Section 3

Top holdings

Concentrated top holdings

Top holdings show which underlying securities drive the fund most.

Tempus AI, Inc. Class A Common Stock
9.22%
Twist Bioscience Corp
9.17%
Crispr Therapeutics AG
8.68%
10X Genomics Inc
5.79%
Beam Therapeutics Inc
5.43%
Absci Corp
4.67%
Illumina Inc
4.26%
Natera Inc
4.04%
Intellia Therapeutics Inc
3.71%
Personalis Inc
3.70%
Section 4

Performance & risk

Historical return and risk indicators over fixed windows.

Returns

YTD return 4.59%
1M return 27.04%
6M return 62.69%
1Y return 94.14%
3Y return 1.24%
5Y return -41.67%
10Y return 6.49%

Risk

Volatility (1Y) 44.52%
Volatility (3Y) 39.55%
Sharpe ratio (3Y) 0.10
Beta 2.53
52-week range 20.26 - 34.39
Section 5

Portfolio characteristics

Fund concentration and composition metrics from source fields.

Overview

Holdings count 29
Top 10 weight 58.68%
Expense ratio 0.75%
Fund size 1.25B
Turnover 28.00%
Avg. market cap 3.03K

Details

Instrument metadata and source update timestamps.

Symbol ARKG
Name ARK Genomic Revolution ETF
Asset type ETF
Exchange BATS
Currency USD
ISIN US00214Q3020
Country USA
Code + exchange ARKG.BATS
Fundamentals updated 2026-05-07

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.